GlassScriptPhysician profile
Randall John Bjork
NPI 1265434112
$16,418.69
in general payments reported to CMS, 2019-2025
63 companies · $2,887 in 2025
The $2,887 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $112 · 2021: $2,398 · 2022: $5,050 · 2023: $2,703 · 2024: $2,716 · 2025: $2,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,304 · Education: $1.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,304.35 |
| Education | $1.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,553.50 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Alexion Pharmaceuticals, INC. | $986.67 | 2021-2025 | Ultomiris, Soliris |
| Celgene Corporation | $785.00 | 2022-2025 | Zeposia |
| Janssen Pharmaceuticals, INC | $758.48 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $630.84 | 2019-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $609.73 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Jazz Pharmaceuticals INC. | $590.32 | 2022-2025 | |
| Sk Life Science, INC. | $559.48 | 2021-2025 | Xcopri |
| Biogen, INC. | $545.41 | 2021-2025 | Vumerity, Tysabri, Plegridy |
| Amgen INC. | $537.01 | 2019-2025 | Uplizna |
| Emd Serono, INC. | $519.12 | 2019-2024 | Mavenclad |
| Abbvie INC. | $490.32 | 2021-2025 | Botox |
| Banner Life Sciences, LLC | $432.99 | 2021-2024 | |
| Acadia Pharmaceuticals INC | $418.91 | 2021-2024 | Nuplazid |
| Ucb, INC. | $409.13 | 2019-2025 | Nayzilam, Briviact, Fintepla |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $402.31 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $360.63 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $335.65 | 2021-2025 | Fycompa, Firdapse |
| Biohaven Pharmaceuticals, INC. | $318.77 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $316.62 | 2022 | |
| Tg Therapeutics, INC. | $308.40 | 2023-2025 | |
| Cala Health, INC. | $268.81 | 2022-2024 | Cala Trio, Cala Kiq |
| Astrazeneca Pharmaceuticals LP | $262.60 | 2025 | Wainua |
| Genentech, INC. | $257.46 | 2022-2023 | Ocrevus |
| Otsuka America Pharmaceutical, INC. | $251.14 | 2023-2025 | Rexulti, Nuedexta |
| Lilly USA, LLC | $248.10 | 2019-2025 | Amyvid, Emgality, Reyvow |
| Allergan, INC. | $234.84 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $231.54 | 2021-2024 | Acthar |
| Neurelis, INC. | $226.53 | 2021-2024 | Valtoco |
| Lundbeck LLC | $213.36 | 2021-2023 | Vyepti |
| Mdd US Operations, LLC | $197.70 | 2021-2025 | Apokyn, Apokyn |
| Takeda Pharmaceuticals U.S.A., INC. | $188.94 | 2023-2025 | Hyqvia, Gammagard |
| Novartis Pharmaceuticals Corporation | $181.88 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $179.96 | 2022-2025 | Crexont, Lyvispah, Brekiya |
| Genzyme Corporation | $154.46 | 2021-2025 | |
| Livanova USA, INC. | $137.85 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Vanda Pharmaceuticals INC. | $135.21 | 2025 | Ponvory |
| Boston Scientific Corporation | $121.09 | 2023 | Watchman Access System |
| Genentech USA, INC. | $116.43 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Horizon Therapeutics Plc | $101.51 | 2021-2023 | Uplizna |
| Acorda Therapeutics, INC | $79.29 | 2021-2023 | Inbrija, Ampyra |
| Pfizer INC. | $77.58 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $57.52 | 2025 | Dysport |
| Adamas Pharmaceuticals, INC. | $53.47 | 2021 | |
| Greenwich Biosciences, INC. | $49.19 | 2021 | |
| Axsome Therapeutics, INC. | $47.68 | 2025 | Symbravo |
| Csl Behring | $43.63 | 2022-2025 | Hizentra |
| Tanabe Pharma America, INC. | $42.09 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $41.94 | 2025 | Bafiertam, Tascenso Odt |
| Grifols USA, LLC | $38.32 | 2022 | |
| Scilex Pharmaceuticals INC. | $32.67 | 2024 | |
| Sunovion Pharmaceuticals INC. | $29.46 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $28.73 | 2021-2022 | |
| Tersera Therapeutics LLC | $26.53 | 2025 | Prialt |
| Alnylam Pharmaceuticals INC. | $24.89 | 2023 | Onpattro |
| Octapharma USA, INC. | $23.27 | 2024 | Panzyga |
| Impel Pharmaceuticals INC. | $23.05 | 2023 | Trudhesa |
| C2n Diagnostics, LLC | $22.81 | 2025 | Precivityad2 |
| Janssen Biotech, INC. | $22.25 | 2025 | |
| Springworks Therapeutics, INC. | $21.99 | 2025 | Gomekli |
| Amylyx Pharmaceuticals, INC. | $21.82 | 2023 | Relyvrio |
| Sumitomo Pharma America, INC. | $17.55 | 2023 | Aptiom |
| Upsher-Smith Laboratories LLC | $14.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Bjork listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.